Metlife (MET) Notes Payables (2009 - 2026)

Metlife's Notes Payables history runs 18 years deep, the most recent figure standing at $404.0 million for Q1 2026.

• On a quarterly basis, Notes Payables rose 6.04% year-over-year to $404.0 million in Q1 2026; TTM through Mar 2026 was $404.0 million, a 6.04% increase from a year earlier, with the FY2025 full-year figure at $355.0 million, down 23.66% from the prior year.
• Notes Payables grew to $404.0 million in Q1 2026 per MET's latest filing, from $355.0 million in the prior quarter.
• Across five years, Notes Payables topped out at $465.0 million in Q4 2024 and bottomed at $119.0 million in Q4 2023.
• The 5-year median for Notes Payables is $323.0 million (2022), against an average of $282.8 million.
• Across the five-year window, Notes Payables slumped 50.13% in 2022 and surged 290.76% in 2024, its largest moves.
• Year by year, Notes Payables stood at $175.0 million in 2022, then sank by 32.0% to $119.0 million in 2023, then jumped by 290.76% to $465.0 million in 2024, then decreased by 23.66% to $355.0 million in 2025, then climbed by 13.8% to $404.0 million in 2026.
• Per Business Quant, the three latest MET Notes Payables figures stand at $404.0 million (Q1 2026), $355.0 million (Q4 2025), and $378.0 million (Q3 2025).